Skip to main content
Back to main menu

About Us

How we work

See what triggers an intervention and how supply and logistics allow our teams to respond quickly.

Learn more
How we're run

Discover our governance and what it means to be an association. Find a quick visual guide to our offices around the world.

Learn more
Reports and financials

Read through our annual financial and activity reports, and find out about where our funds come from and how they are spent.

Learn more
Accountability

Read the policies, reports, and plans on how we address issues like racism and reduce our carbon footprint, ensuring our actions align with the highest ethical standards.

Learn more

What we do

Médecins Sans Frontières brings medical humanitarian assistance to victims of conflict, natural disasters, epidemics or healthcare exclusion.

View all topics Activities by country
Featured Cholera Gaza Israel war Mediterranean migration

Where we work

In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.

View all countries
Featured Haiti Palestine Democratic Republic of Congo (DRC)

MSF Websites

A Global Network
Our offices around the world
Our offices around the world
Other Sites
View Resource Centre
MSF Access

MSF Access pushes for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.

GO TO SITE
CRASH

Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.

GO TO SITE
UREPH

Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.

GO TO SITE
ARHP

Based in Barcelona, ARHP documents and reflects on the operational challenges and dilemmas faced by the MSF field teams.

GO TO SITE
MSF Analysis

Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.

GO TO SITE
MSF Supply

This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
MSF Logistique

This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
Amsterdam Procurement Unit

This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.

GO TO SITE
Brazilian Medical Unit

BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.

GO TO SITE
MSF Medical Guidelines

Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.

GO TO SITE
Epicentre

Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.

GO TO SITE
Evaluation Units

Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.

GO TO SITE
LGBTQI+ Inclusion in Health Settings

MSF works with LGBTQI+ populations in many settings over the last 25-30 years. LGBTQI+ people face healthcare disparities with limited access to care and higher disease rates than the general population.

GO TO SITE
LUXOR

The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.

GO TO SITE
MSF Academy for Healthcare

To upskill and provide training to locally-hired MSF staff in several countries, MSF has created the MSF Academy for Healthcare.

GO TO SITE
Humanitarian Law

This Guide explains the terms, concepts, and rules of humanitarian law in accessible and reader-friendly alphabetical entries.

GO TO SITE
MSF Paediatric Days

The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.

GO TO SITE
MSF Foundation

The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.

GO TO SITE
DNDi

A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.

GO TO SITE
MSF Science Portal

Our digital portal dedicated to sharing the latest medical evidence from our humanitarian activities around the globe.

GO TO SITE
Noma

Noma is a preventable and treatable neglected disease, but 90 per cent of people will die within the first two weeks of infection if they do not receive treatment.

GO TO SITE
TIC

The TIC is aiming to change how MSF works to better meet the evolving needs of our patients.

GO TO SITE
Telemedicine

MSF's telemedicine hub aims to overcome geographic barriers for equitable, accessible, and quality patient care.

GO TO SITE
Sweden Innovation Unit

Launched in 2012, the MSF Sweden Innovation Unit deploys a human-centered approach for promoting a culture of innovation within MSF.

GO TO SITE
Geo MSF

The GeoMSF platform is a dynamic one-stop-shop website for all of MSF's GIS related services and products. Access maps and applications through the catalogue, request geographical support, or produce a map on GeoMSF.

GeoMSF
Ebola disease in DRC: find out how we're responding
Learn more
7998 Results
 
All healthcare workers must wear full Personal Protective Gear (PPEs). Before they cross over into the hot zone, or patient area at ELWA3. A mirror next to the entrance reminds them to check their PPEs for any holes or openings. This could mean the difference between life and death. ELWA3 is the Ebola Case Management Center run by MSF in Monrovia.
Ebola and haemorrhagic fevers

Ebola 2014-2015 Facts & Figures

Through this short report, MSF would like to provide transparency about its expenditure linked to the worst Ebola outbreak in history.
 Report - 23 Mar 2016
 
A staff member puts on PPE equipment as they prepare to enter the isolation area at the MSF Ebola treatment center in Nongo.
Ebola and haemorrhagic fevers

Ebola Activity Update - March 2016

Crisis Update - 23 Mar 2016
 
Refugees and migrans walk along a muddy path, lined with rubbish as they wait to be registered at the Moria Reception Centre in Lesbos, Greece.
Greece

MSF ends activities inside the Lesvos hotspot

Press Release - 22 Mar 2016
Humanitarian challenges

Opportunities, limits and challenges of perceptions studies for humanitarian contexts

MSF's Research Unit on Humanitarian Stakes and Practices (UREPH) is pleased to announce the publication of the article "Opportunities, limits and challenges of perceptions studies for humanitarian contexts" by Elysée Nouvet, Caroline Abu Sa'Da et al., in the Canadian Journal of Development Studies.

 Journal article - 21 Mar 2016
 
At the transit camp at Idomeni, on the Greek - Macedonian (FYROM) border.
Mediterranean migration

EU Migration Crisis Update - March 2016

The EU/Turkey deal is not a solution to the refugee crisis. As other deterrence measures, this cynical agreement will not stop people from crossing the sea or from looking for more dangerous roads in the hands of smugglers Crisis Update - 21 Mar 2016
 
National Reference Laboratory, Abovyan. Sputum culture is currently used to detect TB, together with chest X-rays, sputum smear microscopy and Mantoux test. However, the growth of TB bacteria in culture is the only method allowing determining complete drug-susceptibility.<br>*** Local Caption *** Treatment options for patients with drug-resistant TB remain far short of what is needed. Treatments are long (up to 2 years), toxic (serious side-effects) and expensive. Furthermore, the cure rate is only 50%. Bedaquiline, one of two new TB drugs to be developed in 50 years, is as yet only available for compassionate use, i.e., patients for whom most antibiotics are not effective. MSF has been administering a new treatment including bedaquiline to around thirty patients in Armenia since April 2013. Although we can not draw any definitive conclusions (at this point), several patients have shown significant signs of improvement and we have not observed any side effects associated with bedaquiline until now. But, while compassionate use of this new drug gives cause for optimism to patients who have lost hope, it is not the solution for treating the hundreds of thousands of patients worldwide suffering from DR-TB. New, shorter, less toxic and cheaper treatments including bedaquiline and delamanid, the other new TB drug, need to be developed.
Tuberculosis

Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments

Two years after two new drugs to treat tuberculosis – the first in over 50 years – were conditionally approved for use, only 2% of the 150,000 people who need them have been able to access them, according to Médecins Sans Frontières (MSF). Report - 21 Mar 2016
 
A man looks through the border fence into Macedonia (FYROM).
Refugees, IDPs and people on the move

Trapped at Europe's borders

Despite the winter conditions and attempts to close the various routes available to them, refugees and migrants have not stopped fleeing war and disaster. Since the beginning of 2016, more than 153,158 people have arrived in Europe, mainly by crossing the Aegean Sea between Turkey and Greece. In the past weeks, as stricter measures have been implemented by the countries along the so called ‘Balkan Route.’ Leaving many people stranded along the borders of Serbia, Macedonia (FYROM) and Greece. Photo Story - 18 Mar 2016
 
Syrian refugees are blocked at the Greek border with Macedonia (FYROM)
Mediterranean migration

Why the EU’s deal with Turkey is no solution to the “crisis” affecting Europe

Interview with Aurélie Ponthieu, MSF Humanitarian Adviser on Displacement, Brussels. Project Update - 18 Mar 2016
 
People watching for afar the dismantling of shelters in Calais' Jungle.
France

More than 4,000 migrants still entrenched in Calais Jungle

Project Update - 17 Mar 2016
 
Zwara, April 19th 2016. In one of the two operating theater of the marine Hospital.
Libya

Health system in a state of hidden crisis

Project Update - 17 Mar 2016
Four mothers posing in a corridor of the Hospital in Bili. All four of them are staying in the hospital with their child, that's suffering from a severe case of malaria. Since the beginning of the project in 2016, the pediatric ward already treated more than 4.000 cases of complicated/severe form of malaria.
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more